1. Home
  2. BOLT vs JTAI Comparison

BOLT vs JTAI Comparison

Compare BOLT & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • JTAI
  • Stock Information
  • Founded
  • BOLT 2015
  • JTAI 2018
  • Country
  • BOLT United States
  • JTAI United States
  • Employees
  • BOLT N/A
  • JTAI N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • JTAI Blank Checks
  • Sector
  • BOLT Health Care
  • JTAI Finance
  • Exchange
  • BOLT Nasdaq
  • JTAI Nasdaq
  • Market Cap
  • BOLT 10.4M
  • JTAI 8.3M
  • IPO Year
  • BOLT 2021
  • JTAI N/A
  • Fundamental
  • Price
  • BOLT $6.17
  • JTAI $3.01
  • Analyst Decision
  • BOLT Buy
  • JTAI Strong Buy
  • Analyst Count
  • BOLT 3
  • JTAI 1
  • Target Price
  • BOLT $47.50
  • JTAI $11.00
  • AVG Volume (30 Days)
  • BOLT 33.8K
  • JTAI 138.7K
  • Earning Date
  • BOLT 11-11-2025
  • JTAI 11-13-2025
  • Dividend Yield
  • BOLT N/A
  • JTAI N/A
  • EPS Growth
  • BOLT N/A
  • JTAI N/A
  • EPS
  • BOLT N/A
  • JTAI N/A
  • Revenue
  • BOLT $4,167,000.00
  • JTAI $12,790,684.00
  • Revenue This Year
  • BOLT N/A
  • JTAI N/A
  • Revenue Next Year
  • BOLT N/A
  • JTAI N/A
  • P/E Ratio
  • BOLT N/A
  • JTAI N/A
  • Revenue Growth
  • BOLT N/A
  • JTAI N/A
  • 52 Week Low
  • BOLT $4.59
  • JTAI $2.30
  • 52 Week High
  • BOLT $14.36
  • JTAI $57.17
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 63.23
  • JTAI 37.00
  • Support Level
  • BOLT $5.13
  • JTAI $3.27
  • Resistance Level
  • BOLT $6.20
  • JTAI $3.46
  • Average True Range (ATR)
  • BOLT 0.32
  • JTAI 0.24
  • MACD
  • BOLT 0.07
  • JTAI -0.05
  • Stochastic Oscillator
  • BOLT 87.19
  • JTAI 2.80

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as through Jet Token's leased and managed aircraft.

Share on Social Networks: